Substantial burden imposed by enteroviral meningitis in the US

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.301, 2001-01, pp. : 9-9

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antineoplastics/rituximab: Enteroviral aseptic meningitis: case report

Reactions Weekly, Vol. 1, Iss. 1419, 2012-01 ,pp. : 9-10

Adis International

Access to resources Recommend Favorite

Alcoholism burden substantial in Scotland

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 385, 2002-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

MS poses substantial employer burden

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 588, 2009-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Musculoskeletal disorders: substantial economic burden

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 323, 2001-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Enteroviral Meningitis: Cost of Illness and Considerations for the Economic Evaluation of Potential Therapies

By Parasuraman T.V.

PharmacoEconomics, Vol. 19, Iss. 1, 2001-01 ,pp. : 3-12

Adis International

Access to resources Recommend Favorite